290 related articles for article (PubMed ID: 24607147)
41. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.
Bertram L; Lange C; Mullin K; Parkinson M; Hsiao M; Hogan MF; Schjeide BM; Hooli B; Divito J; Ionita I; Jiang H; Laird N; Moscarillo T; Ohlsen KL; Elliott K; Wang X; Hu-Lince D; Ryder M; Murphy A; Wagner SL; Blacker D; Becker KD; Tanzi RE
Am J Hum Genet; 2008 Nov; 83(5):623-32. PubMed ID: 18976728
[TBL] [Abstract][Full Text] [Related]
42. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.
Lambert JC; Ibrahim-Verbaas CA; Harold D; Naj AC; Sims R; Bellenguez C; DeStafano AL; Bis JC; Beecham GW; Grenier-Boley B; Russo G; Thorton-Wells TA; Jones N; Smith AV; Chouraki V; Thomas C; Ikram MA; Zelenika D; Vardarajan BN; Kamatani Y; Lin CF; Gerrish A; Schmidt H; Kunkle B; Dunstan ML; Ruiz A; Bihoreau MT; Choi SH; Reitz C; Pasquier F; Cruchaga C; Craig D; Amin N; Berr C; Lopez OL; De Jager PL; Deramecourt V; Johnston JA; Evans D; Lovestone S; Letenneur L; Morón FJ; Rubinsztein DC; Eiriksdottir G; Sleegers K; Goate AM; Fiévet N; Huentelman MW; Gill M; Brown K; Kamboh MI; Keller L; Barberger-Gateau P; McGuiness B; Larson EB; Green R; Myers AJ; Dufouil C; Todd S; Wallon D; Love S; Rogaeva E; Gallacher J; St George-Hyslop P; Clarimon J; Lleo A; Bayer A; Tsuang DW; Yu L; Tsolaki M; Bossù P; Spalletta G; Proitsi P; Collinge J; Sorbi S; Sanchez-Garcia F; Fox NC; Hardy J; Deniz Naranjo MC; Bosco P; Clarke R; Brayne C; Galimberti D; Mancuso M; Matthews F; ; ; ; ; Moebus S; Mecocci P; Del Zompo M; Maier W; Hampel H; Pilotto A; Bullido M; Panza F; Caffarra P; Nacmias B; Gilbert JR; Mayhaus M; Lannefelt L; Hakonarson H; Pichler S; Carrasquillo MM; Ingelsson M; Beekly D; Alvarez V; Zou F; Valladares O; Younkin SG; Coto E; Hamilton-Nelson KL; Gu W; Razquin C; Pastor P; Mateo I; Owen MJ; Faber KM; Jonsson PV; Combarros O; O'Donovan MC; Cantwell LB; Soininen H; Blacker D; Mead S; Mosley TH; Bennett DA; Harris TB; Fratiglioni L; Holmes C; de Bruijn RF; Passmore P; Montine TJ; Bettens K; Rotter JI; Brice A; Morgan K; Foroud TM; Kukull WA; Hannequin D; Powell JF; Nalls MA; Ritchie K; Lunetta KL; Kauwe JS; Boerwinkle E; Riemenschneider M; Boada M; Hiltuenen M; Martin ER; Schmidt R; Rujescu D; Wang LS; Dartigues JF; Mayeux R; Tzourio C; Hofman A; Nöthen MM; Graff C; Psaty BM; Jones L; Haines JL; Holmans PA; Lathrop M; Pericak-Vance MA; Launer LJ; Farrer LA; van Duijn CM; Van Broeckhoven C; Moskvina V; Seshadri S; Williams J; Schellenberg GD; Amouyel P
Nat Genet; 2013 Dec; 45(12):1452-8. PubMed ID: 24162737
[TBL] [Abstract][Full Text] [Related]
43. Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.
Karch CM; Ezerskiy LA; Bertelsen S; ; Goate AM
PLoS One; 2016; 11(2):e0148717. PubMed ID: 26919393
[TBL] [Abstract][Full Text] [Related]
44. Somatostatin genetic variants modify the risk for Alzheimer's disease among Finnish patients.
Vepsäläinen S; Helisalmi S; Koivisto AM; Tapaninen T; Hiltunen M; Soininen H
J Neurol; 2007 Nov; 254(11):1504-8. PubMed ID: 17987251
[TBL] [Abstract][Full Text] [Related]
45. APOE and MS4A6A interact with GnRH signaling in Alzheimer's disease: Enrichment of epistatic effects.
Cáceres A; Vargas JE; González JR
Alzheimers Dement; 2017 Apr; 13(4):493-497. PubMed ID: 27337227
[TBL] [Abstract][Full Text] [Related]
46. TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity.
Maruszak A; Pepłońska B; Safranow K; Chodakowska-Żebrowska M; Barcikowska M; Zekanowski C
J Alzheimers Dis; 2012; 28(2):309-22. PubMed ID: 22008263
[TBL] [Abstract][Full Text] [Related]
47. Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS).
Shi H; Belbin O; Medway C; Brown K; Kalsheker N; Carrasquillo M; Proitsi P; Powell J; Lovestone S; Goate A; Younkin S; Passmore P; ; Morgan K;
Neurobiol Aging; 2012 Aug; 33(8):1849.e5-18. PubMed ID: 22445811
[TBL] [Abstract][Full Text] [Related]
48. Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping.
Belloy ME; Eger SJ; Le Guen Y; Damotte V; Ahmad S; Ikram MA; Ramirez A; Tsolaki AC; Rossi G; Jansen IE; de Rojas I; Parveen K; Sleegers K; Ingelsson M; Hiltunen M; Amin N; Andreassen O; Sánchez-Juan P; Kehoe P; Amouyel P; Sims R; Frikke-Schmidt R; van der Flier WM; Lambert JC; ; He Z; Han SS; Napolioni V; Greicius MD
Alzheimers Res Ther; 2022 Feb; 14(1):22. PubMed ID: 35120553
[TBL] [Abstract][Full Text] [Related]
49. SORL1 is genetically associated with neuropathologically characterized late-onset Alzheimer's disease.
Wen Y; Miyashita A; Kitamura N; Tsukie T; Saito Y; Hatsuta H; Murayama S; Kakita A; Takahashi H; Akatsu H; Yamamoto T; Kosaka K; Yamaguchi H; Akazawa K; Ihara Y; Kuwano R
J Alzheimers Dis; 2013; 35(2):387-94. PubMed ID: 23455993
[TBL] [Abstract][Full Text] [Related]
50. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
[TBL] [Abstract][Full Text] [Related]
51. The genetic variation of ARRB2 is associated with late-onset Alzheimer's disease in Han Chinese.
Jiang T; Yu JT; Wang YL; Wang HF; Zhang W; Hu N; Tan L; Sun L; Tan MS; Zhu XC; Tan L
Curr Alzheimer Res; 2014 May; 11(4):408-12. PubMed ID: 24635845
[TBL] [Abstract][Full Text] [Related]
52. Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer's disease.
Chen SY; Chen TF; Lai LC; Chen JH; Sun Y; Wen LL; Yip PK; Chu YM; Chen YC
J Neuroinflammation; 2012 Jan; 9():21. PubMed ID: 22272811
[TBL] [Abstract][Full Text] [Related]
53. Exome-wide age-of-onset analysis reveals exonic variants in ERN1 and SPPL2C associated with Alzheimer's disease.
He L; Loika Y; Park Y; ; Bennett DA; Kellis M; Kulminski AM;
Transl Psychiatry; 2021 Feb; 11(1):146. PubMed ID: 33637690
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
55. Definition of Late Onset Alzheimer's Disease and Anticipation Effect of Genome-Wide Significant Risk Variants: Pilot Study of the APOE e4 Allele.
De Luca V; Spalletta G; Souza RP; Graff A; Bastos-Rodrigues L; Camargos Bicalho MA
Neuropsychobiology; 2019; 77(1):8-12. PubMed ID: 30110694
[TBL] [Abstract][Full Text] [Related]
56. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
[TBL] [Abstract][Full Text] [Related]
57. A quantitative trait rare variant nonparametric linkage method with application to age-at-onset of Alzheimer's disease.
Zhao L; Zhang Z; Rodriguez SMB; Vardarajan BN; Renton AE; Goate AM; Mayeux R; Wang GT; Leal SM
Eur J Hum Genet; 2020 Dec; 28(12):1734-1742. PubMed ID: 32740652
[TBL] [Abstract][Full Text] [Related]
58. Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease.
Cruchaga C; Kauwe JS; Nowotny P; Bales K; Pickering EH; Mayo K; Bertelsen S; Hinrichs A; ; Fagan AM; Holtzman DM; Morris JC; Goate AM
Hum Mol Genet; 2012 Oct; 21(20):4558-71. PubMed ID: 22821396
[TBL] [Abstract][Full Text] [Related]
59. Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
Jiang S; Yang W; Qiu Y; Chen HZ;
Curr Alzheimer Res; 2015; 12(3):218-27. PubMed ID: 25731621
[TBL] [Abstract][Full Text] [Related]
60. [Genetic risk factor of Alzheimer's disease].
Kuwano R
Rinsho Shinkeigaku; 2007 Nov; 47(11):908-11. PubMed ID: 18210832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
